Login / Signup

Biphasic bullous pemphigoid starting after first dose and boosted by second dose of mRNA-1273 vaccine in an 84-year-old female with polymorbidity and polypharmacy.

V SchmidtR BlumMatthias Möhrenschlager
Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2021)
Keyphrases
  • emergency department
  • binding protein
  • adverse drug